Rapport Therapeutics Inc RAPP Q1 2026 Earnings NarrowerThanExpected Loss Drives Stock Gain AA Q1 2026 Earnings EPS Misses Estimates Amid Operational Challenges WYY Q1 2026 Earnings EPS Surges Past Estimates with 108 Surprise AFLAC Q1 2026 Earnings EPS Miss Estimates Amid Stable Operations FCEL Q1 2026 Earnings EPS Surprises to the Upside Shares Dip Despite Narrowing Losses MDXG Q1 2026 Earnings EPS Misses Estimates as GAAP Loss Widens